ANAKINRA
MB24THR
Phase 2 small_molecule active
Quick answer
ANAKINRA for Hyperinflammation, Sepsis is a Phase 2 program (small_molecule) at AXIM BIOTECHNOLOGIES, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AXIM BIOTECHNOLOGIES, INC.
- Indication
- Hyperinflammation, Sepsis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active